EXANE DERIVATIVES - NABRIVA THERAPEUTICS PLC ownership

Back to all holdings Add to watchlist

NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 3 filers reported holding NABRIVA THERAPEUTICS PLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of NABRIVA THERAPEUTICS PLC
ValueSharesWeighting
Q3 2020$71,890,000
-3.2%
134,886
+22.5%
0.02%
+5.0%
Q2 2020$74,256,000
+57.3%
110,078
+34.1%
0.02%
+53.8%
Q1 2020$47,193,000–82,078–0.01%–
 Download
Other shareholders
NABRIVA THERAPEUTICS PLC shareholders Q4 2020
NameSharesValueWeighting ↓
Aisling Capital Management LP 191,028$462,0000.08%
Sterling Investment Advisors, Ltd. 5,000$12,0000.00%
IFP Advisors, Inc 0$00.00%
View complete list of NABRIVA THERAPEUTICS PLC shareholders